New use of antihypertensive medications that stimulated rather than inhibited type 2 and 4 angiotensin II receptors was linked with lower dementia risk. (JAMA Network Open)
Full data about an implanted endovascular brain-computer interface for paralyzed people were reported in JAMA Neurology. Findings were first presented at the 2022 American Academy of Neurology meeting.
A newly discovered meningeal layer appears to line the brain. (Science)
Blood-based measures of neurofilament light chain were associated with neuronal injury in peripheral neuropathy, a meta-analysis showed. (JAMA Network Open)
People with incident Parkinson’s disease had cognitive and functional decline before diagnosis that exceeded rates associated with normal aging. (Neurology)
Jet Medical agreed to pay $200,000 to resolve criminal allegations relating to a migraine treatment, while Jet and two related companies agreed to pay another $545,000 in a civil settlement involving the same device, the Department of Justice said.
Remote observational research provided a “reasonable evaluation” of disability trajectory over time in a multiple sclerosis study during the pandemic. (Neurology: Neuroimmunology and Neuroinflammation)
As soon as lecanemab (Leqembi) received the green light through the FDA’s accelerated approval pathway, Eisai submitted an application for traditional approval of the drug.
Based on its accelerated approval status, who can get lecanemab? (NBC News)
A novel vaccine appeared to protect mice against SARS-CoV-2 brain infection. (Nature Neuroscience)
Researchers identified a unifying functional framework for multiple dimensions of consciousness. (Nature Communications)
Source: MedicalNewsToday.com
